1. Home
  2. LADR vs ANIP Comparison

LADR vs ANIP Comparison

Compare LADR & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LADR
  • ANIP
  • Stock Information
  • Founded
  • LADR 2008
  • ANIP 2001
  • Country
  • LADR United States
  • ANIP United States
  • Employees
  • LADR N/A
  • ANIP N/A
  • Industry
  • LADR Real Estate Investment Trusts
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • LADR Real Estate
  • ANIP Health Care
  • Exchange
  • LADR Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • LADR 1.5B
  • ANIP 1.2B
  • IPO Year
  • LADR 2014
  • ANIP N/A
  • Fundamental
  • Price
  • LADR $11.14
  • ANIP $54.60
  • Analyst Decision
  • LADR Buy
  • ANIP Buy
  • Analyst Count
  • LADR 6
  • ANIP 7
  • Target Price
  • LADR $13.33
  • ANIP $77.33
  • AVG Volume (30 Days)
  • LADR 643.0K
  • ANIP 277.5K
  • Earning Date
  • LADR 02-06-2025
  • ANIP 02-27-2025
  • Dividend Yield
  • LADR 8.22%
  • ANIP N/A
  • EPS Growth
  • LADR N/A
  • ANIP N/A
  • EPS
  • LADR 0.76
  • ANIP N/A
  • Revenue
  • LADR $257,005,000.00
  • ANIP $555,456,000.00
  • Revenue This Year
  • LADR N/A
  • ANIP $25.48
  • Revenue Next Year
  • LADR N/A
  • ANIP $20.24
  • P/E Ratio
  • LADR $14.67
  • ANIP N/A
  • Revenue Growth
  • LADR N/A
  • ANIP 23.60
  • 52 Week Low
  • LADR $10.10
  • ANIP $52.50
  • 52 Week High
  • LADR $12.48
  • ANIP $70.81
  • Technical
  • Relative Strength Index (RSI)
  • LADR 37.23
  • ANIP 44.00
  • Support Level
  • LADR $11.07
  • ANIP $53.15
  • Resistance Level
  • LADR $11.97
  • ANIP $56.63
  • Average True Range (ATR)
  • LADR 0.24
  • ANIP 1.70
  • MACD
  • LADR -0.04
  • ANIP 0.08
  • Stochastic Oscillator
  • LADR 11.17
  • ANIP 43.48

About LADR Ladder Capital Corp

Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments include loans: which derives maximum profit; securities; and real estate.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: